{"id":16039,"date":"2023-04-26T11:46:11","date_gmt":"2023-04-26T04:46:11","guid":{"rendered":"https:\/\/farmalkes.kemkes.go.id\/?p=16039"},"modified":"2024-03-26T08:08:01","modified_gmt":"2024-03-26T01:08:01","slug":"informasi-penggunaan-paxlovid-untuk-pengobatan-covid-19","status":"publish","type":"post","link":"https:\/\/farmalkes.kemkes.go.id\/en\/2023\/04\/informasi-penggunaan-paxlovid-untuk-pengobatan-covid-19\/","title":{"rendered":"Information on the Use of Paxlovid for the Treatment of COVID-19"},"content":{"rendered":"<p class=\"has-drop-cap translation-block\">There is no drug approved by the Food and Drug Administration (FDA) to specifically treat COVID-19. The use of Paxlovid may be beneficial for adult COVID-19 patients who do not require supplemental oxygen and who are at high risk of progression to severe COVID-19.<\/p>\n\n\n\n<p class=\" translation-block\">The following Patient Information Leaflet (PIL) contains information regarding the benefits and risks of using Paxlovid. Please consult your healthcare professional if you have any further questions.<\/p>\n\n\n\n<p>Information regarding the drug Paxlovid can be downloaded at the following link.<\/p>\n\n\n<div class='w3eden'><!-- WPDM Link Template: Default Template -->\n\n<div class=\"link-template-default card mb-2\">\n    <div class=\"card-body\">\n        <div class=\"media\">\n            <div class=\"mr-3 img-90\"><\/div>\n            <div class=\"media-body\">\n                <h3 class=\"package-title\"><a href='https:\/\/farmalkes.kemkes.go.id\/en\/unduh\/materi-leaflet-paxlovid-nirmatrelvir-150-ritonavir-100\/'>Paxlovid Leaflet Material (Nirmatrelvir 150, Ritonavir 100)<\/a><\/h3>\n                <div class=\"text-muted text-small\"><i class=\"fas fa-copy\"><\/i> 1 dokumen <i class=\"fas fa-hdd ml-3\"><\/i> 654.83 KB<\/div>\n            <\/div>\n            <div class=\"ml-3\">\n                <a class='wpdm-download-link download-on-click btn btn-primary' target=\"_blank\" rel='nofollow' href='#' data-downloadurl=\"https:\/\/farmalkes.kemkes.go.id\/en\/unduh\/materi-leaflet-paxlovid-nirmatrelvir-150-ritonavir-100\/?wpdmdl=16037&refresh=69e566d80ad701776641752\">Download<\/a>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":15985,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,2],"tags":[229,128,968,958],"class_list":["post-16039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artikel","category-berita-utama","tag-covid-19","tag-obat-2","tag-obat-covid-19","tag-paxlovid"],"acf":[],"_links":{"self":[{"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/posts\/16039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/comments?post=16039"}],"version-history":[{"count":2,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/posts\/16039\/revisions"}],"predecessor-version":[{"id":180828,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/posts\/16039\/revisions\/180828"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/media\/15985"}],"wp:attachment":[{"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/media?parent=16039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/categories?post=16039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmalkes.kemkes.go.id\/en\/wp-json\/wp\/v2\/tags?post=16039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}